Report Highlights
The global patient monitoring device (PMD) market is expected to grow from nearly $14.7 billion in 2013 to reach nearly $21.0 billion in 2018, a compound annual growth rate (CAGR) of 7.4% for the period of 2013 to 2018.
Report Includes
- An overview of the global market for patient monitoring devices, accessories, and consumables that are used to measure, display, and document physiological information obtained at regular intervals over time from sensors attached to the patient or other input devices.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Examination of the market for patient monitoring devices and related equipment by application (e.g., intensive care, neonatal/pediatric care), product type (central monitoring stations, portable bedside monitors, wireless/telemetry monitors), and target markets (hospitals, long-term care facilities, and individual consumers).
- Discussion of promising new technologies and products still in the development and testing stages that are likely to be commercialized successfully in the next five years.
- Comprehensive company profiles of major players in the industry.
SCOPE OF REPORT
The report includes only those products and end users that are noted above and that fall within the parameters of the four geographical regions noted.
Discussion and analysis covers the following market factors:
- Key market analysis.
- Strategic recommendations.
- Market dynamics (drivers and constraints).
- Market forecast for the period of 2013 through 2018.
- Competitive developments and general landscape.
- Geographical analysis.
- Profiles of key market players.
- Patents.
Analyst Credentials
Himani Singhi has been working in healthcare, biotechnology and life sciences business research and consulting since 2009. She has expertise in business strategy, market and competitive intelligence, business performance measurement and management, business analysis and analytics, and forecasting. Himani studied in the U.K. and holds double masters, one in life sciences/allied science and the other in business analysis.
Report Highlights
- The U.S. market for patient monitoring devices, accessories, and consumables was worth nearly $6.2 billion in 2007. The market is projected to grow to almost $6.5 billion in 2008 and $8.6 billion by 2013, representing a compound annual growth rate (CAGR) of 5.7%.
- The monitoring devices segment has the largest share of the market, worth $3.6 billion in 2007 and an estimated $3.8 billion in 2008. This is expected to grow at a CAGR of 6.2% to reach $5.1 billion in 2013.
- Disposable sensors and other consumables generated $2.6 billion in 2007. This should increase to $2.7 billion in 2008 and $3.4 billion in 2013, for a CAGR of 5.1%.
Report Highlights
-
The U.S. market for patient monitoring devices and related consumable supplies such as disposable sensors was worth an estimated $4.3 billion in 2005. The market is projected to grow to $4.6 billion in 2006 and $6.3 billion by 2011, an AAGR of 6.7%.
-
The home-care market has the highest projected growth rate of any market segment (i.e., an average of 13.8% between 2006-2011). Other segments with relatively high growth rates include progressive care/cardio-pulmonary rehabilitation (4.8%) and long term/non-acute care (4.0%).
-
Across the market, there has been a noticeable trend away from bedside and tabletop monitors, towards hand-held and wearable monitors. With a projected growth rate of 12.8%, the market for hand-held and wearable monitors is expected to grow from $1 billion in 2005 (46% of the market, excluding consumables) to over $2 billion (59%) in 2011.
Report Highlights
-
The U.S. market will rise to $4.3 billion by 2008, at an average annual growth rate (AAGR) of 8.1%.
-
The home care market has the highest growth rate of any market segment.
-
Averaging 11.7%/year, the handheld monitor market will reach $1.6 billion in 2008.
-
The phone or wireless telemetry monitor market will reach $405 million in 2008.
Related Reports
Global Markets for Telemedicine Technologies
The global telehome and telemedicine market reached $13.8 billion 2012. This market is expected to grow to $16.1 billion 2013 and $35.1 billion in 2018 with a compound annual growth (CAGR) of 16.9%.
Global Markets and Technologies for Home Medical Equipment
The global market for home medical equipment (HME) was worth $17.9 billion in 2010, nearly $19 billion in 2011, and is expected to reach $26.2 billion by 2016, a CAGR of 6.7%.
Microelectronic Medical Implants: Products, Technologies & Opportunities
The global market for microelectronic medical implants, accessories, and supplies was worth an estimated $15.4 billion in 2010. The market is projected to grow to $16.3 billion in 2011 and $24.8 billion in 2016, a compound annual growth rate (CAGR) of 8.8%, between 2011 and 2016.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More